GB Sciences, Inc. (GBLX)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
-0.0003 (-37.50%)
Mar 17, 2025, 4:00 PM EST
GB Sciences Company Description
GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company.
The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market.
Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs.
The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016.
GB Sciences, Inc. is based in Las Vegas, Nevada.
GB Sciences, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
Contact Details
Address: 9205 W. Russell Road Las Vegas, Nevada 89148 United States | |
| Phone | 866 721 0297 |
| Website | gbsciences.com |
Stock Details
| Ticker Symbol | GBLX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US3615441090 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Andrea Small-Howard M.B.A., MBA, Ph.D. | Chairman of Scientific Advisory Board, Chief Science Officer, President and Director |